These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 11926130)

  • 21. Drug resistance in cancer - searching for mechanisms, markers and therapeutic agents.
    O'Connor R; Clynes M; Dowling P; O'Donovan N; O'Driscoll L
    Expert Opin Drug Metab Toxicol; 2007 Dec; 3(6):805-17. PubMed ID: 18028026
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Amphipathic peptide-based fusion peptides and immunoconjugates for the targeted ablation of prostate cancer cells.
    Rege K; Patel SJ; Megeed Z; Yarmush ML
    Cancer Res; 2007 Jul; 67(13):6368-75. PubMed ID: 17616696
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Anti-tumor chemotherapy utilizing peptide-based approaches--apoptotic pathways, kinases, and proteasome as targets.
    Mendoza FJ; Espino PS; Cann KL; Bristow N; McCrea K; Los M
    Arch Immunol Ther Exp (Warsz); 2005; 53(1):47-60. PubMed ID: 15761376
    [TBL] [Abstract][Full Text] [Related]  

  • 24. TMTP1, a novel tumor-homing peptide specifically targeting metastasis.
    Yang W; Luo D; Wang S; Wang R; Chen R; Liu Y; Zhu T; Ma X; Liu R; Xu G; Meng L; Lu Y; Zhou J; Ma D
    Clin Cancer Res; 2008 Sep; 14(17):5494-502. PubMed ID: 18765541
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Nanoparticle therapeutics: an emerging treatment modality for cancer.
    Davis ME; Chen ZG; Shin DM
    Nat Rev Drug Discov; 2008 Sep; 7(9):771-82. PubMed ID: 18758474
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Cholecystokinin-B (CCK-B)/gastrin receptor targeting peptides for staging and therapy of medullary thyroid cancer and other CCK-B receptor expressing malignancies.
    Béhé M; Behr TM
    Biopolymers; 2002; 66(6):399-418. PubMed ID: 12658727
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Therapeutic peptides for cancer therapy. Part II - cell cycle inhibitory peptides and apoptosis-inducing peptides.
    Raucher D; Moktan S; Massodi I; Bidwell GL
    Expert Opin Drug Deliv; 2009 Oct; 6(10):1049-64. PubMed ID: 19743895
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Ligandomics--a tool for the development of targeted treatments].
    Porkka K; Laakkonen P
    Duodecim; 2002; 118(11):1185-92. PubMed ID: 12239852
    [No Abstract]   [Full Text] [Related]  

  • 29. Review: nanoparticles in drug delivery for the treatment of cancer.
    Arayne MS; Sultana N
    Pak J Pharm Sci; 2006 Jul; 19(3):258-68. PubMed ID: 16935836
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Phage display selection of peptides that inhibit metastasis ability of gastric cancer cells with high liver-metastatic potential.
    Hu S; Guo X; Xie H; Du Y; Pan Y; Shi Y; Wang J; Hong L; Han S; Zhang D; Huang D; Zhang K; Bai F; Jiang H; Zhai H; Nie Y; Wu K; Fan D
    Biochem Biophys Res Commun; 2006 Mar; 341(4):964-72. PubMed ID: 16458253
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The inhibitor of apoptosis protein family (IAPs): an emerging therapeutic target in cancer.
    Nachmias B; Ashhab Y; Ben-Yehuda D
    Semin Cancer Biol; 2004 Aug; 14(4):231-43. PubMed ID: 15219616
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Biophysical delivery of peptides: applicability for cancer therapy.
    Dass CR; Choong PF
    Peptides; 2006 Dec; 27(12):3479-88. PubMed ID: 16996648
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Synthesis of chemically modified bioactive peptides: recent advances, challenges and developments for medicinal chemistry.
    Gracia SR; Gaus K; Sewald N
    Future Med Chem; 2009 Oct; 1(7):1289-310. PubMed ID: 21426104
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Manufacturing peptides as active pharmaceutical ingredients.
    Zompra AA; Galanis AS; Werbitzky O; Albericio F
    Future Med Chem; 2009 May; 1(2):361-77. PubMed ID: 21425973
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Peptide aptamers: recent developments for cancer therapy.
    Borghouts C; Kunz C; Groner B
    Expert Opin Biol Ther; 2005 Jun; 5(6):783-97. PubMed ID: 15952909
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Therapeutic peptides for chemotherapy: Trends and challenges for advanced delivery systems.
    Ilangala AB; Lechanteur A; Fillet M; Piel G
    Eur J Pharm Biopharm; 2021 Oct; 167():140-158. PubMed ID: 34311093
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Peptide-Based Therapeutics for Oncology.
    Fisher E; Pavlenko K; Vlasov A; Ramenskaya G
    Pharmaceut Med; 2019 Feb; 33(1):9-20. PubMed ID: 31933267
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Towards intracellular delivery of peptides.
    Marzinzik AL; Vorherr TE
    Chimia (Aarau); 2013; 67(12-13):899-904. PubMed ID: 24594335
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Therapeutic peptides revisited.
    Latham PW
    Nat Biotechnol; 1999 Aug; 17(8):755-7. PubMed ID: 10429238
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Development of membrane-active peptide therapeutics in oncology.
    Chen CH; Zan B; Ulmschneider JP; Wimley WC; Lu TK; Ulmschneider MB; Zhou L
    J Pept Sci; 2023 Aug; 29(8):e3482. PubMed ID: 36739581
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.